TCL Archive FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness” September 3, 1976
TCL Archive In Brief: NCI Contract Plans Shaping Up As RFP “Season” Approaches; L-B Profit Told September 13, 1974
TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms April 6, 2012